These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 31159216)

  • 1. Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine.
    O'Brien F; Clapham D; Krysiak K; Batchelor H; Field P; Caivano G; Pertile M; Nunn A; Tuleu C
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Paediatric Formulation Initiative workshop report: Improving the administration of oral liquid medicines in paediatrics using dosing syringes and enteral accessories.
    Walsh J; van Riet-Nales D; Hermans E; de Vries R; Hilton G; Blowers P; Salunke S
    Eur J Pharm Biopharm; 2020 Jun; 151():91-97. PubMed ID: 32289491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paediatric oral biopharmaceutics: key considerations and current challenges.
    Batchelor HK; Fotaki N; Klein S
    Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges Associated with Route of Administration in Neonatal Drug Delivery.
    Linakis MW; Roberts JK; Lala AC; Spigarelli MG; Medlicott NJ; Reith DM; Ward RM; Sherwin CM
    Clin Pharmacokinet; 2016 Feb; 55(2):185-96. PubMed ID: 26245673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of unlicensed and off-label medicines in the neonate.
    Conroy S; McIntyre J
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):115-22. PubMed ID: 15701577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formulation and special investigations of innovative intraoral solid dosage forms.].
    Kristo K; kATONA B; Piukovics P; Olah I; Sipos B; Sipos SE; Sovany T; Hodi K; Ifi Regdon G
    Acta Pharm Hung; 2016; 86(3):99-111. PubMed ID: 29489081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery and formulations.
    Breitkreutz J; Boos J
    Handb Exp Pharmacol; 2011; 205():91-107. PubMed ID: 21882107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of different oral dosage forms in paediatric patients in hospital setting.
    Pokharkar V; Sajith M; Vallet T; Akshantal S; Shah R; Ruiz F; Salunke S
    Arch Dis Child; 2022 Sep; 107(9):796-801. PubMed ID: 34799375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations.
    Martir J; Flanagan T; Mann J; Fotaki N
    AAPS J; 2020 Mar; 22(2):54. PubMed ID: 32133550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of inhaled drugs for infants and small children: a commentary on present and future needs.
    Fink JB
    Clin Ther; 2012 Nov; 34(11):S36-45. PubMed ID: 23149011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients.
    Walsh J; Cram A; Woertz K; Breitkreutz J; Winzenburg G; Turner R; Tuleu C;
    Adv Drug Deliv Rev; 2014 Jun; 73():14-33. PubMed ID: 24614069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric drug development: formulation considerations.
    Ali AA; Charoo NA; Abdallah DB
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1283-99. PubMed ID: 24483293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational paper: formulation-related issues in pediatric clinical pharmacology.
    Tuleu C; Breitkreutz J
    Eur J Pediatr; 2013 Jun; 172(6):717-20. PubMed ID: 23111761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation strategies and particle engineering technologies for pulmonary delivery of biopharmaceuticals.
    Cun D; Wan F; Yang M
    Curr Pharm Des; 2015; 21(19):2599-610. PubMed ID: 25876915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.